Dr. Reddy's Laboratories is a global pharmaceutical company focused on accelerating access to affordable and innovative medicines. The company operates across four main segments: Generics (branded, unbranded, and biosimilars), Active Pharmaceutical Ingredients (API) & Services, Innovative Medicines, and Consumer Health solutions.
With a presence in over 100 countries, Dr. Reddy's is committed to improving patient outcomes through research, development, and partnerships. The company emphasizes innovation, quality, safety, and sustainability in its operations and aims to expand access to critical treatments in high-burden regions.
Dr. Reddy's leverages global collaborations in research and manufacturing to bring new therapies to market, including biosimilars and novel molecules, while maintaining a strong commitment to ethical practices and environmental responsibility.
